- Active Pharmaceutical Ingredients
- Varenicline tartrate
- Aprepitant, Fosapitant Intermediates
- Fosaprepitant Dimeglumine
- Vildagliptin
- Efinaconazole
- Luliconazole Intermediate
- Gadoterate Meglumine
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- Varenicline tartrate 230615-70-0
- Aprepitant 287930-73-8
- Aprepitant 127852-28-2
- Aprepitant 287930-75-0
- Aprepitant 200000-59-5
- Aprepitant 155742-64-6
- Aprepitant 252742-72-6
- Fosaprepitant Dimeglumine 990-91-0
- Fosaprepitant Dimeglumine 265121-01-5
- Vildagliptin 207557-35-5
- Vildagliptin 702-82-9
- Efinaconazole 144230-50-2
- Efinaconazole 133775-25-4
- Efinaconazole 127000-90-2
- Gadoterate Meglumine
- Mirabegron
- Luliconazole 98873-55-3
- Luliconazole 126534-31-4
- Atazanavir sulfate
- Bortezomib 179324-87-9
- Bortezomib 114457-94-2
- Bortezomib 205393-22-2
- Brinzolamide
- Rivaroxaban Intermediate 446292-08-6
- Rivaroxaban Intermediate 446292-07-5
- Cinacalcet Hydrochloride 1005450-55-4
- Cinacalcet Hydrochloride 585-50-2
- Eletriptan Intermediate
- Indacaterol intermediate 312753-53-0
- Indacaterol intermediate 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Indacaterol intermediate 312753-53-0
【Catalog Number】AP4507
【CAS #】312753-53-0
【Molecular Formula】C13H20ClN
【Molecular Weight】225.76
|
Alias |
Indate maleate intermediate |
|
Catalog Number |
AP4507 |
|
CAS # |
312753-53-0 |
|
Molecular Formula |
C13H20ClN |
|
Molecular Weight |
225.76 |
|
Structural Formula |
|
|
Product Introduction CAS 312753-53-0 |
5,6-diethyl-2,3-dihydro-1H-indene-2-amine hydrochloride, English name 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride, American Chemical Abstracts Registry Number cas 312753-53-0. 5,6-Diethyl-2,3-dihydro-1H-indene-2-amine hydrochloride (cas 312753-53-0) is an intermediate of indate maleate. Indate maleate is a bronchodilator, belongs to the class of long-acting inhaled β2 receptor agonists (LABA), and is suitable for maintenance treatment of adult patients with chronic obstructive pulmonary disease. Indacaterol has a 5 minute onset and lasts 24 hours. This product is produced by Novartis Pharmaceuticals, Switzerland, and has been marketed in more than 70 countries and regions around the world since 2009; it was approved for listing in China by the State Drug Administration in June 2012 under the trade name Onbrez®. |
VIWIT 沪ICP备12014533号-2
